Back
Introduction: Crush injury related acute kidney injury (CR-AKI) needs to be recognized early to enable initiation of renal protection strategies. Primary objective of this study was to compare the diagnostic performance of urinary biomarker (product of TIMP-2 and IGFBP-7) vs RRI in predicting AKI
Adult patients with a history suggestive of crush injury were recruited prospectively from the triage of a level 1 trauma centre from September 2022 – June 2023. Measurements of RRI and collection of urine samples for IGFBP-7 and TIMP -2 were done thrice (within 2 hours of admission, 24 and 48 hours). AKI was diagnosed using KDIGO criteria based on serum creatinine values analysed on a daily basis till 7th day of hospital admission.
Clinical and demographic data was collected from 118 patients (140 were assessed; 22 were excluded). Incidence of CR-AKI was 33.05%. RRI was significantly higher at all time points in patients developing AKI. Product of TIMP-2 and IGFBP-7 at all time points in both the groups expressed as (ng/ml)2 /1000 were > 0.3 and the difference in values in the AKI vs non AKI groups was significantly different at 2 hours and 48hrs. Best diagnostic parameter for CR-AKI was RRI at 24 hours; area under ROC (AUROC) curve was 0.744. At a cut off of RRI ≥0.665 it predicted AKI with a sensitivity, specificity, NPV, OR of 78.9%, 69.6%, 87.3% , 8.59 (p= <0.001) respectively. AUROC was <0.7 for all urinary biomarkers
Table 1: Demographic and clinical characteristics of overall cohort with crush injury and subsequent subgroup; AKI vs non AKI
Parameters
Overall (n=118)
AKI (n=39)
Non AKI (n=79)
P value
Age (years)
Weight (kg)
Height (cm)
BMI (Kg/m²)
Male:Female*
34.75 ±13.38
70.64 ±11.31
167.05±8.32
25.41 ±3.87
108:10
35.41±13.54
70.13±10.91
167.54±8.96
25.34±3.96
37:2
34.42±13.38
70.89±11.57
166.81±8.04
25.44±3.85
71:8
0.693
0.635
0.515
0.630
0.494
ASA class I:II*
99:19
31:8
68:11
0.360
Delay in Admission#
<24 Hours
24-48 Hours
>48 Hours
Conclusions
All patients with crush injury are at risk of AKI. RRI performs better than urinary biomarkers for early diagnosis of AKI.